Noa K, Christodouleas J, Dolney D, Both S, Kassaee A
University Pennsylvania, Philadelphia, PA.
Med Phys. 2012 Jun;39(6Part19):3844. doi: 10.1118/1.4735691.
Radiotherapy planning for iliac pelvic nodes can be challenging due to the close proximity of sensitive healthy tissues such as the bowel and rectum. Modern treatment techniques like photon intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) offer improved healthy tissue sparing for similar target coverage. In this study we compare IMRT and IMPT plans for six post-cystectomy patients.
A dose of 50.4 Gy was prescribed to the planning target volume (PTV), which for IMRT is the clinical target volume (CTV) plus a 5 mm expansion for geometric uncertainties due to CTV and patient positioning errors, and for proton beams is the CTV plus the lateral 5 mm margin plus an additional longitudinal margin to allow for the proton range uncertainty. The optimization objectives are: 98% of the PTV receive at least 95% of the prescription, target maximum dose = 107% of prescription, rectum V[40Gy] < 30% and max = 105%, and bowel V[45Gy] < 125 cc and max = 107%. All IMRT and IMPT plans are made to achieve the target coverage objective.
Using IMPT, the rectum would receive a mean dose of 9.0 Gy with an average (over the six patients) maximum dose of 38.1 Gy. Using IMRT, the rectum would receive a mean dose of 13.0 Gy and an average maximum dose of 37.6 Gy. The IMPT plans give a mean dose of 17.9 Gy and a maximum dose of 53.4 Gy for the bowel, whereas the IMRT plans give a mean dose of 23.8 Gy and a maximum dose of 53.2 Gy. Both the rectum and bowel show slightly lower mean doses for IMPT.
Our results indicate that IMPT plans improve normal tissue sparing as compared to IMRT plans and provide adequate dose coverage of the target volume.
由于肠道和直肠等敏感健康组织距离髂盆腔淋巴结较近,因此对其进行放射治疗计划颇具挑战性。像光子调强放射治疗(IMRT)和调强质子治疗(IMPT)等现代治疗技术,在实现相似靶区覆盖的情况下,能更好地保护健康组织。在本研究中,我们比较了6例膀胱切除术后患者的IMRT和IMPT计划。
计划靶体积(PTV)的处方剂量为50.4 Gy,对于IMRT,PTV是临床靶体积(CTV)加上因CTV和患者体位误差导致的5 mm几何不确定性扩展;对于质子束,PTV是CTV加上5 mm的侧向边界以及额外的纵向边界,以考虑质子射程的不确定性。优化目标为:98%的PTV接受至少95%的处方剂量,靶区最大剂量 = 处方剂量的107%,直肠V[40Gy] < 30%且最大值 = 105%,肠道V[45Gy] < 125 cc且最大值 = 107%。所有IMRT和IMPT计划均旨在实现靶区覆盖目标。
使用IMPT时,直肠的平均剂量为9.0 Gy,6例患者的平均最大剂量为38.1 Gy。使用IMRT时,直肠的平均剂量为13.0 Gy,平均最大剂量为37.6 Gy。IMPT计划中肠道的平均剂量为17.9 Gy,最大剂量为53.4 Gy,而IMRT计划中肠道的平均剂量为23.8 Gy,最大剂量为53.2 Gy。IMPT对直肠和肠道的平均剂量均略低。
我们的结果表明,与IMRT计划相比,IMPT计划能更好地保护正常组织,并为靶区提供足够的剂量覆盖。